Thromboprophylaxis in hip arthroplasty - New frontiers and future strategy

被引:14
作者
Dahl, OE [1 ]
机构
[1] Ullevaal Univ Hosp, Dept Orthopaed, Res Forum, NO-0407 Oslo, Norway
来源
ACTA ORTHOPAEDICA SCANDINAVICA | 1998年 / 69卷 / 04期
关键词
D O I
10.3109/17453679808999042
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Coagulation-related complications are a frequent cause of death following hip replacement surgery. Venographically-proven deep vein thrombosis (DVT) is found in a high frequency. Most cases have no symptoms. Fatal pulmonary embolism (PE) may develop from subclinical thrombi. In addition, arterial thromboses may induce serious cardiovascular events and an unknown number of patients may develop cardiorespiratory insufficiency, due to non-fatal venous PE, Finally, several patients may develop venous insufficiency. Recent prospective double-blind studies have shown that the frequency of deep vein thrombosis increased after hospital discharge in patients undergoing hip replacement surgery. Prolonged thromboprophylaxis with low-molecular-weight heparin (dalteparin or enoxaparin) is recommended for at least 5 weeks after the operation.
引用
收藏
页码:339 / 342
页数:4
相关论文
共 37 条
  • [1] AGNELLI G, 1995, THROMB HAEMOSTASIS, V74, P1042
  • [2] ANDREASSEN G, 1997, TIDSSKR NOR LAEGEFOR, V14, P2026
  • [3] Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
    Bergqvist, D
    Benoni, G
    Bjorgell, O
    Fredin, H
    Hedlundh, U
    Nicolas, S
    Nilsson, P
    Nylander, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (10) : 696 - 700
  • [4] Campling E., 1993, The report of the National Confidential Enquiry into Perioperative Death 1991/1992. Available at
  • [5] CAMPLING EA, 1994, REPORT NATL CONFIDEN
  • [6] Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis
    Clarke, MT
    Green, JS
    Harper, WM
    Gregg, PJ
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1997, 79B (05): : 787 - 791
  • [7] A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
    Cohen, M
    Demers, C
    Gurfinkel, EP
    Turpie, AGG
    Fromell, GJ
    Goodman, S
    Langer, A
    Califf, RM
    Fox, KAA
    Premmereur, J
    Bigonzi, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) : 447 - 452
  • [8] INCREASED ACTIVATION OF COAGULATION AND FORMATION OF LATE DEEP VENOUS THROMBOSIS FOLLOWING DISCONTINUATION OF THROMBOPROPHYLAXIS AFTER HIP-REPLACEMENT SURGERY
    DAHL, OE
    ASPELIN, T
    ARNESEN, H
    SELJEFLOT, I
    KIERULF, P
    RUYTER, R
    LYBERG, T
    [J]. THROMBOSIS RESEARCH, 1995, 80 (04) : 299 - 306
  • [9] Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26
  • [10] SEQUENTIAL INTRAPULMONARY AND SYSTEMIC ACTIVATION OF COAGULATION AND FIBRINOLYSIS DURING AND AFTER TOTAL HIP-REPLACEMENT SURGERY
    DAHL, OE
    PEDERSEN, T
    KIERULF, P
    WESTVIK, AB
    LUND, P
    ARNESEN, H
    SELJEFLOT, I
    ABDELNOOR, M
    LYBERG, T
    [J]. THROMBOSIS RESEARCH, 1993, 70 (06) : 451 - 458